2011
DOI: 10.1086/662022
|View full text |Cite
|
Sign up to set email alerts
|

QuantiFERON-TB Testing for Latent Tuberculosis Infection in Low-Prevalence Countries: Making the Most of an Imperfect Process

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Patients with influenza who require hospitalisation tend not to present with classic influenza-like illness (ILI), therefore relying on ILI presentations to identify patients suffering serious influenza infections or influenza-related complications is inadequate [10]. A substantial proportion of patients admitted to intensive care with pneumonia or respiratory infection are found to be positive for influenza, if an appropriate test is performed in a timely manner [11].…”
Section: Introductionmentioning
confidence: 99%
“…Patients with influenza who require hospitalisation tend not to present with classic influenza-like illness (ILI), therefore relying on ILI presentations to identify patients suffering serious influenza infections or influenza-related complications is inadequate [10]. A substantial proportion of patients admitted to intensive care with pneumonia or respiratory infection are found to be positive for influenza, if an appropriate test is performed in a timely manner [11].…”
Section: Introductionmentioning
confidence: 99%
“…Thus, while both TST and IGRAs are impacted by nonspecific variations, conversions and reversions during serial testing, IGRAs appear to have a very high frequency of conversions and reversions, and the consequences of such changes are unclear, posing challenges for implementation in routine occupational health programs. Indeed, a series of recent studies have described the challenges faced by US hospitals that switched to IGRA for HCW screening after the 2005 CDC guideline (15,17,(25)(26)(27)(28).…”
mentioning
confidence: 99%